TEVA

Teva Pharmaceutical Industries Limited

16.89 USD
-0.12 (-0.71%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Teva Pharmaceutical Industries Limited stock is up 1.81% since 30 days ago. The next earnings date is Jul 31, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 51.43% of the previous 34 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 10 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
17 Jun 15:31 20 Sep, 2024 17.00 CALL 200 19132
17 Jun 15:58 20 Sep, 2024 14.00 CALL 100 28763
17 Jun 17:34 17 Jan, 2025 18.00 CALL 134 9731
18 Jun 15:06 17 Jan, 2025 16.00 CALL 189 3300
18 Jun 16:53 21 Jun, 2024 7.00 CALL 55 458
18 Jun 18:37 21 Jun, 2024 13.00 CALL 246 81676
20 Jun 13:58 20 Sep, 2024 14.00 CALL 100 28638
20 Jun 14:00 20 Sep, 2024 14.00 CALL 100 28638
20 Jun 15:06 17 Jan, 2025 15.00 CALL 83 35148
20 Jun 16:29 21 Jun, 2024 17.00 CALL 1800 8363

About Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited sells generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. Its products in the central nervous system, pain, respiratory, and oncology areas include Copaxone for the treatment of relapsing forms of multiple sclerosis. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

  • Barclays
    Wed Jun 5, 11:19
    buy
    confirm
  • Bank of America
    Thu May 30, 11:44
    buy
    confirm